Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2025 Earnings Call Transcript May 13, 2025
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.63.
Operator: Welcome to the Conference Call hosted by Daré Bioscience to review the company’s First Quarter 2025 Financial Results and to provide the Business Update. This call is being recorded. My name is Gayle [ph], and I’ll be your operator today. With us today from Daré are Sabrina Martucci Johnson,...
